Antibody-Drug Conjugates (ADC) Technology Research and Global Markets Report 2024-2025 & 2029 with Profiles of Leading Players - F. Hoffmann-La Roche., Daiichi Sankyo, Pfizer, and Gilead Sciences
04. November 2024 07:00 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global sales of ADCs on...
Small Molecule Drug Discovery Market Research Report 2024-2030: Surge in Pipeline Molecules and Expiry of Key Biologic Patents Drives Small Molecule Drug Development
24. Oktober 2024 09:36 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Drug Discovery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
24. Oktober 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, Tenn., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today that its Fourth Quarter 2024 Investor Update will...
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
10. Oktober 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today that it will host a conference call on Thursday,...
Antibody Drug Conjugates Industry Report (2024-2032) Featuring Profiles the Top 13 Players - ADC Therapeutics, Astellas Pharma, AstraZeneca, Celldex Therapeutics, Roche & More
09. Oktober 2024 10:13 ET
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report by Component, Target, Application, End-user, and Region 2024-2032" report has been added to ...
Therapeutics (Biologics, Biosimilars, Small Molecules) Research Report 2024-2030 with Analyst Recommendations - Focus on Personalized Medicine & Targeted therapy with Nanomedicine
01. Oktober 2024 06:27 ET
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By...
Degrader-Antibody Conjugates (DAC) Landscape Report 2024: Stakeholders, Platform Technologies, Development and Discovery Pipelines and Partnering Deals
10. September 2024 12:36 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective" report...
Drug Discovery Services Market Forecast to 2030: Discover the Leading Strategic and Regional Growth Trends Major Players are Capitalizing On
30. August 2024 06:53 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug...
Targeted Therapeutics Market is Pioneering Growth Towards a USD 118.6 Billion Milestone by 2031, with a CAGR of 6.4% - Exclusive Report by Transparency Market Research, Inc.
22. August 2024 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 22, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global targeted...
Janus Kinase (JAK) Inhibitor Therapeutic Report 2024: Strategic Evaluation of Over 50 Companies and 55+ Pipeline Drugs
15. August 2024 11:04 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...